PEEl-388

N/A

Report date: 2025/10/15 17:03:25
NME

Base Information

Drug NamePEEl-388
Drug Alias NamePEEl-388
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeel Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeel Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A